Clinical Study

Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration

Table 1

Baseline characteristics of study and control population.

Control groupStudy group value

Age (in years) 0.2

Sex (female : male)4 : 267 : 230.1

Race (African American : Caucasian)26 : 41 : 290.001

Aqueous VEGF levels (in picogram) 0.002

Aqueous IL-6 levels (in picogram) <0.0001